跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,157 条关于
“NXT-41”
全部
6,157
临床试验
4,024
药物
592
机构
132
资讯
1,409
去年
Boston Scientific Acquires Elutia's BioEnvelope Business for $88 Million, Fueling Breast Reconstruction Pipeline
6个月前
Elutia Appoints Pete Ligotti as CCO to Lead NXT-41x Commercial Launch in $1.5B Breast Reconstruction Market
9个月前
Federal Appeals Court Overturns $41 Million Patent Verdict Against Daiichi Sankyo's Enhertu ADC
2年前
Roche's Columvi Demonstrates 41% Reduction in Death Risk in Phase III DLBCL Trial
去年
ClearFlow's PleuraFlow System Reduces Cardiac Surgery Complications by 41% in Large Clinical Trial
去年
KisoJi Biotechnology Secures $41 Million to Advance TROP2-Targeting Antibody into Clinical Trials
去年
Moderna Reports 41% Revenue Decline in Q2 2025, Launches $1.5 Billion Cost-Cutting Initiative
4个月前
Sunnybrook Health Sciences Centre Receives $41 Million Donation to Transform Clinical Trial Infrastructure in Canada
2年前
Ultra-Sensitive Blood Test Predicts Breast Cancer Recurrence Up to 41 Months Before Clinical Symptoms
8天前
Ondine's LANTERN Phase III Trial Hits Primary Endpoint With 41% Reduction in Surgical Site Infections
第 1 页,共 141 页
上一页
下一页